His primary scientific interests are in Internal medicine, Cardiology, Heart failure, Endocrinology and Ischemia. His works in Ejection fraction, Heart disease, Natriuretic peptide, Hemodynamics and Myocardial infarction are all subjects of inquiry into Internal medicine. His work deals with themes such as Prospective cohort study, Disease and Diastole, which intersect with Cardiology.
His study in the field of Levosimendan, Dilated cardiomyopathy and Cardiomyopathy also crosses realms of In patient. The study incorporates disciplines such as Proinflammatory cytokine, Inflammation, Oleuropein and Pathogenesis in addition to Endocrinology. His studies deal with areas such as Anesthesia and Cholesterol as well as Ischemia.
His primary areas of study are Internal medicine, Cardiology, Heart failure, Anesthesia and Endocrinology. Dimitrios Th. Kremastinos conducted interdisciplinary study in his works that combined Internal medicine and In patient. His work carried out in the field of Cardiology brings together such families of science as Blood pressure and Diastole.
His Heart failure study frequently draws connections between related disciplines such as Quality of life. In his study, which falls under the umbrella issue of Anesthesia, Pharmacology is strongly linked to Ischemia. Particularly relevant to Simvastatin is his body of work in Endocrinology.
Dimitrios Th. Kremastinos focuses on Internal medicine, Cardiology, Heart failure, Ejection fraction and Coronary artery disease. His Internal medicine research is multidisciplinary, relying on both Endocrinology and Surgery. His work in the fields of Cardiology, such as Natriuretic peptide, overlaps with other areas such as In patient.
His biological study spans a wide range of topics, including Quality of life, Beck Depression Inventory, Renal function and Confidence interval. His Ejection fraction research incorporates elements of Cardiomyopathy and Crossover study. His Coronary artery disease study combines topics in areas such as Artery, Scintigraphy, Chest pain and Receiver operating characteristic.
His primary areas of investigation include Internal medicine, Cardiology, Ejection fraction, Heart failure and Endocrinology. His work in Internal medicine is not limited to one particular discipline; it also encompasses Surgery. His Cardiology study integrates concerns from other disciplines, such as Disease, Diastole and Hazard ratio.
His Ejection fraction research incorporates themes from Cardiomyopathy, Dilated cardiomyopathy, Vascular disease and Renal function. His research integrates issues of Survival rate and Emergency department in his study of Heart failure. His Oxidative stress study combines topics from a wide range of disciplines, such as Proinflammatory cytokine, Anesthesia and Beck Depression Inventory, Depression.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea : results from the BACH (Biomarkers in Acute Heart Failure) trial
Alan Maisel;Christian Mueller;Richard Nowak;W. Frank Peacock.
Journal of the American College of Cardiology (2010)
Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human
Kobra Haghighi;Fotis Kolokathis;Luke Pater;Roy A. Lynch.
Journal of Clinical Investigation (2003)
Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention
Konstantinos Spargias;Elias Alexopoulos;Stamatis Kyrzopoulos;Panayiotis Iacovis.
Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation
Stavroula N. Psychari;Thomas S. Apostolou;Loukas Sinos;Eftihia Hamodraka.
American Journal of Cardiology (2005)
Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation.
Nikolaos Dagres;Robby Nieuwlaat;Panos E. Vardas;Dietrich Andresen.
Journal of the American College of Cardiology (2007)
Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fasligand system in patients with chronic heart failure
Stamatis Adamopoulos;John Parissis;Dimitrios Karatzas;Christos Kroupis.
Journal of the American College of Cardiology (2002)
The Olive Constituent Oleuropein Exhibits Anti-Ischemic, Antioxidative, and Hypolipidemic Effects in Anesthetized Rabbits
Ioanna Andreadou;Efstathios K. Iliodromitis;Emmanuel Mikros;Maria Constantinou.
Journal of Nutrition (2006)
Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
Ignatios Ikonomidis;John P. Lekakis;Maria Nikolaou;Ioannis Paraskevaidis.
Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation.
John Lekakis;Pierre Abraham;Alberto Balbarini;Andrew Blann.
European Journal of Preventive Cardiology (2011)
A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy
Kobra Haghighi;Fotis Kolokathis;Anthony O. Gramolini;Jason R. Waggoner.
Proceedings of the National Academy of Sciences of the United States of America (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: